Recent Advances in Drug Treatment for Endometriosis in Adolescents

文静 孔

doi:10.12677/jcpm.2025.46490

Recent Advances in Drug Treatment for Endometriosis in Adolescents

文静孔

In: Journal of Clinical Personalized Medicine · 2025 · vol. 04(06) , pp. 150–159 · doi:10.12677/jcpm.2025.46490 · W4416777524

article OA: diamond CC0

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews recent advances in drug treatments for endometriosis, focusing on therapeutic options and their efficacy in adolescent patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (56)

A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis via openalex
Adolescent Endometriosis via openalex
Advances in the medical treatment of adolescent endometriosis via openalex
A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment via openalex
Antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans: a systematic review and meta-analysis via openalex
Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis via openalex
Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma via openalex
Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery via openalex
Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis via openalex
Diagnosis and management of endometriosis via openalex
DNA methylation in endometriosis (Review) via openalex
Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis via openalex
Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes via openalex
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review via openalex
Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications via openalex
Endometriosis in adolescent and young women via openalex
Endometriosis in the Adolescent Patient via openalex
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis via openalex
Identification of potential repurposed drugs for treating endometriosis-associated infertility among women via openalex
Immunotherapy: A promising novel endometriosis therapy via openalex
Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin via openalex
Management of endometriosis: a call to multidisciplinary approach via openalex
New therapeutic approaches for endometriosis besides hormonal therapy via openalex
Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions via openalex
Protective effect of cabergoline on mitochondrial oxidative stress-induced apoptosis is mediated by modulations of TRPM2 in neutrophils of patients with endometriosis via openalex
Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases via openalex
Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis via openalex
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials via openalex
The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology via openalex
The effect of GnRH-a on the angiogenesis of endometriosis via openalex
The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions via openalex
Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex
Traitement médical de l’endométriose douloureuse chez l’adolescente, RPC Endométriose CNGOF-HAS via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
W4214754424 via openalex
W4200296862 via openalex
W4367313225 via openalex
W3111066944 via openalex
W4386250780 via openalex
W3104692881 via openalex
W4387640260 via openalex
W2969981788 via openalex
W4389946953 via openalex
W2943380091 via openalex
W4391251799 via openalex
W4391973279 via openalex
W4392208240 via openalex
W2915366423 via openalex
W4401350192 via openalex
W4402876312 via openalex
W4403013414 via openalex
W4405777572 via openalex
W2552451329 via openalex
W4285745216 via openalex
W4410241557 via openalex
W4239615232 via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis via openalex

[2] Adolescent Endometriosis via openalex

[3] Advances in the medical treatment of adolescent endometriosis via openalex

[4] A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment via openalex

[5] Antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans: a systematic review and meta-analysis via openalex

[6] Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis via openalex

[7] Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma via openalex

[8] Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery via openalex

[9] Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis via openalex

[10] Diagnosis and management of endometriosis via openalex

[11] DNA methylation in endometriosis (Review) via openalex

[12] Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis via openalex

[13] Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes via openalex

[14] Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review via openalex

[15] Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications via openalex

[16] Endometriosis in adolescent and young women via openalex

[17] Endometriosis in the Adolescent Patient via openalex

[18] Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis via openalex

[19] Identification of potential repurposed drugs for treating endometriosis-associated infertility among women via openalex

[20] Immunotherapy: A promising novel endometriosis therapy via openalex

[21] Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin via openalex

[22] Management of endometriosis: a call to multidisciplinary approach via openalex

[23] New therapeutic approaches for endometriosis besides hormonal therapy via openalex

[24] Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions via openalex

[25] Protective effect of cabergoline on mitochondrial oxidative stress-induced apoptosis is mediated by modulations of TRPM2 in neutrophils of patients with endometriosis via openalex

[26] Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases via openalex

[27] Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis via openalex

[28] State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials via openalex

[29] The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology via openalex

[30] The effect of GnRH-a on the angiogenesis of endometriosis via openalex

[31] The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions via openalex

[32] Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex

[33] Traitement médical de l’endométriose douloureuse chez l’adolescente, RPC Endométriose CNGOF-HAS via openalex

[34] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex

[35] W4214754424 via openalex

[36] W4200296862 via openalex

[37] W4367313225 via openalex

[38] W3111066944 via openalex

[39] W4386250780 via openalex

[40] W3104692881 via openalex

[41] W4387640260 via openalex

[42] W2969981788 via openalex

[43] W4389946953 via openalex

[44] W2943380091 via openalex

[45] W4391251799 via openalex

[46] W4391973279 via openalex

[47] W4392208240 via openalex

[48] W2915366423 via openalex

[49] W4401350192 via openalex

[50] W4402876312 via openalex

[51] W4403013414 via openalex

[52] W4405777572 via openalex

[53] W2552451329 via openalex

[54] W4285745216 via openalex

[55] W4410241557 via openalex

[56] W4239615232 via openalex